Page last updated: 2024-08-24

tenofovir and End Stage Liver Disease

tenofovir has been researched along with End Stage Liver Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Chang, ML; Cheng, JS; Chien, RN; Lee, KC; Liaw, YF1
He, S; Wang, L; Wang, N; Zheng, Y1
Chan, AC; Cheung, TT; Chok, KS; Dai, WC; Fung, J; Lai, CL; Lo, CM; Ma, KW; Mak, LY; Seto, WK; She, WH; Sin, SL; Wong, TC; Yuen, MF1
Anugwom, CM; Bane, A; Braimoh, GA; Debes, JD; Sultan, A; Wondifraw, Z1
Chun, JM; Han, YS; Hur, K; Jang, SY; Kang, MK; Kweon, YO; Lee, HJ; Lee, HW; Lee, YR; Park, JG; Park, SY; Tak, WY1
Akarsu, M; Astarcıoğlu, İ; Hakim, GD; Karademir, S; Unek, T1
Liu, T; Wang, Y; Zhang, C1

Reviews

1 review(s) available for tenofovir and End Stage Liver Disease

ArticleYear
Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis.
    BMC gastroenterology, 2023, Nov-13, Volume: 23, Issue:1

    Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; End Stage Liver Disease; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Prospective Studies; Retrospective Studies; Severity of Illness Index; Tenofovir; Treatment Outcome

2023

Other Studies

6 other study(ies) available for tenofovir and End Stage Liver Disease

ArticleYear
Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study.
    Hepatology international, 2022, Volume: 16, Issue:4

    Topics: Antiviral Agents; Cohort Studies; End Stage Liver Disease; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Tenofovir; Treatment Outcome

2022
Model for End-Stage Liver Disease With Additional Criteria to Predict Short-Term Mortality in Severe Flares of Chronic Hepatitis B.
    Hepatology (Baltimore, Md.), 2020, Volume: 72, Issue:3

    Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; End Stage Liver Disease; Female; Guanine; Hepatitis B, Chronic; Hong Kong; Humans; Liver Function Tests; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Severity of Illness Index; Tenofovir

2020
Single center analysis of therapy and outcomes of hepatocellular carcinoma in Sub-Saharan Africa.
    Expert review of gastroenterology & hepatology, 2020, Volume: 14, Issue:10

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Doxorubicin; End Stage Liver Disease; Ethiodized Oil; Ethiopia; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Palliative Care; Retrospective Studies; Severity of Illness Index; Sorafenib; Survival Rate; Tenofovir; Treatment Outcome

2020
Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2018, Volume: 50, Issue:2

    Topics: Adult; Antiviral Agents; Disease Progression; DNA, Viral; Drug Resistance, Viral; End Stage Liver Disease; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Republic of Korea; ROC Curve; Severity of Illness Index; Tenofovir; Treatment Outcome

2018
The efficacy and safety of tenofovir in the prevention of hepatitis B virus recurrence following liver transplantation.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2014, Volume: 25, Issue:6

    Topics: Adenine; Antiviral Agents; End Stage Liver Disease; Female; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome

2014
Proper antiviral therapy for hepatitis B virus-associated acute-on-chronic liver failure.
    Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:2

    Topics: Adenine; Antiviral Agents; End Stage Liver Disease; Guanine; Hepatitis B, Chronic; Humans; Liver Failure, Acute; Organophosphonates; Tenofovir

2011